Cipla has announced that its Emerging Markets & Europe Business Unit (EMEU BU) has achieved a new milestone by being recognized in the Asia Book of Records.

During the Chronic Obstructive Pulmonary Disease (COPD) Awareness Month, the company engaged 4,350 doctors from Nepal, Myanmar, Sri Lanka, Malaysia, Oman, and the UAE in a pledge campaign to raise awareness about COPD.

The initiative, titled “Take Charge – I Pledge,” aimed to foster meaningful dialogue between healthcare professionals, patients, and caregivers, reinforcing Cipla’s commitment to respiratory disease awareness, the company said in a statement.

Commenting on this recognition, Swapn Malpani, CEO – Cipla EMEU said, “COPD is recognized as a progressive lung condition and ranks as the fourth leading cause of death worldwide. In 2021, it accounted for about 3.5 million deaths, which is roughly 5% of all deaths globally. By encouraging doctors to participate in the “Take Charge – I Pledge” campaign, our aim was to highlight the significance of timely diagnosis and effective management in enhancing long-term health outcomes. The campaign aimed to strengthen the doctor-patient relationship by promoting open dialogue, which can result in better understanding and improved care for those living with COPD.”